CD5 ‐negative chronic lymphocytic leukemia: Does this entity really exist?
2023; Wiley; Volume: 106; Issue: 2 Linguagem: Inglês
10.1002/cyto.b.22151
ISSN1552-4957
Autores Tópico(s)Immunodeficiency and Autoimmune Disorders
ResumoCytometry Part B: Clinical CytometryEarly View DISCUSSION FORUM CD5-negative chronic lymphocytic leukemia: Does this entity really exist? Daniel Mazza Matos, Corresponding Author Daniel Mazza Matos [email protected] orcid.org/0000-0002-6793-0101 Flow Cytometry Section, Cell Processing Center (CPC), Center of Hematology and Hemotherapy of Ceará (HEMOCE), Fortaleza, Brazil Correspondence Daniel Mazza Matos, Center of Hematology and Hemotherapy of Ceará (HEMOCE), Avenida José Bastos, 3390, Fortaleza, CE 60431-086, Brazil. Email: [email protected]Search for more papers by this author Daniel Mazza Matos, Corresponding Author Daniel Mazza Matos [email protected] orcid.org/0000-0002-6793-0101 Flow Cytometry Section, Cell Processing Center (CPC), Center of Hematology and Hemotherapy of Ceará (HEMOCE), Fortaleza, Brazil Correspondence Daniel Mazza Matos, Center of Hematology and Hemotherapy of Ceará (HEMOCE), Avenida José Bastos, 3390, Fortaleza, CE 60431-086, Brazil. Email: [email protected]Search for more papers by this author First published: 28 November 2023 https://doi.org/10.1002/cyto.b.22151Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Albakr, A., Alhothali, W., Samghabadi, P., Maeda, L., Nagpal, S., & Ajlan, A. (2018). Central nervous system lymphoma in a patient with chronic lymphocytic leukemia: A case report and literature review. Cureus, 10, e3660. PubMedWeb of Science®Google Scholar Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, J., Jr., Lu, L., Lewis, D. B., Tibshirani, R., Sherlock, G., … Staudt, L. M. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503–511. 10.1038/35000501 CASPubMedWeb of Science®Google Scholar Asplund, S. L., McKenna, R. W., Howard, M. S., & Kroft, S. H. (2002). Immunophenotype does not correlate with lymph node histology in chronic lymphocytic leukemia/small lymphocytic lymphoma. American Journal of Surgical Pathology, 26, 624–629. 10.1097/00000478-200205000-00008 PubMedWeb of Science®Google Scholar Bahler, D. W., Aguilera, N. S., Chen, C. C., Abbondanzo, S. L., & Swerdlow, S. H. (2000). Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types. American Journal of Pathology, 157, 1063–1070. 10.1016/S0002-9440(10)64620-2 CASPubMedWeb of Science®Google Scholar Basabaeen, A. A., Abdelgader, E. A., Babekir, E. A., Abdelateif, N. M., Abdelrahim, S. O., Altayeb, O. A., Fadul, E. A., Osman, H. A., Bamusa, S. A., & Ibrahim, I. K. (2022). Characteristics of chronic lymphocytic leukemia in Sudanese patients. Asian Pacific Journal of Cancer Care, 7(3), 467–474. 10.31557/apjcc.2022.7.3.467-474 Google Scholar Bassan, R., Pronesti, M., Buzzetti, M., Viero, P., Minetti, B., Comotti, B., Buelli, M., & Barbui, T. (1987). Surface immunoglobulin intensivity and p67 (CD5) antigen expression define different forms of B-cell chronic lymphocytic leukaemia. Haematologica, 72, 221–225. CASPubMedWeb of Science®Google Scholar Batata, A., & Shen, B. (1992). Relationship between chronic lymphocytic leukemia and small lymphocytic lymphoma. A comparative study of membrane phenotypes in 270 cases. Cancer, 70, 625–632. 10.1002/1097-0142(19920801)70:3 3.0.CO;2-D CASPubMedWeb of Science®Google Scholar Caligaris-Cappio, F., Gobbi, M., Bofill, M., & Janossy, G. (1982). Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. Journal of Experimental Medicine, 155, 623–628. 10.1084/jem.155.2.623 CASPubMedWeb of Science®Google Scholar Carbone, A., Pinto, A., Gloghini, A., Volpe, R., & Zagonel, V. (1992). B-zone small lymphocytic lymphoma: A morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders. Human Pathology, 23, 438–448. 10.1016/0046-8177(92)90092-H CASPubMedWeb of Science®Google Scholar Cartron, G., Linassier, C., Bremond, J. L., Desablens, B., Georget, M. T., Fimbel, B., Luthier, F., Dutel, J. L., Lamagnere, J. P., & Colombat, P. (1998). CD5 negative B-cell chronic lymphocytic leukemia: Clinical and biological features of 42 cases. Leukemia Lymphoma, 31, 209–216. 10.3109/10428199809057600 CASPubMedWeb of Science®Google Scholar Catovsky, D., Else, M., & Oscier, D. (2019). In D. Catovsky, B. Eichhorst, & M. Hallek (Eds.), The clinical presentation of CLL. Chronic lymphocytic leukemia ( 1st ed., pp. 39–50). Springer International Publishing. Google Scholar Chang, J. C., Harrington, A. M., Olteanu, H., VanTuinen, P., & Kroft, S. H. (2016). Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: A clinicopathologic analysis. Annals of Diagnostic Pathology, 25, 15–19. 10.1016/j.anndiagpath.2016.07.011 PubMedWeb of Science®Google Scholar Chen, D., Zhan, Y., Peng, J., & Yao, F. (2019). CD5-negative chronic lymphocytic leukemia/small lymphocytic lymphoma in a patient with gastrointestinal mantle cell lymphoma: An unusual case report. Oncotargets and Therapy, 12, 2937–2941. 10.2147/OTT.S193014 CASPubMedWeb of Science®Google Scholar Criel, A., Michaux, L., & De Wolf-Peeters, C. (1999). The concept of typical and atypical chronic lymphocytic leukaemia. Leukemia Lymphoma, 33, 33–45. 10.3109/10428199909093723 CASPubMedWeb of Science®Google Scholar Criel, A., Wlodarska, I., Meeus, P., Stul, M., Louwagie, A., Van Hoof, A., Hidajat, M., Mecucci, C., & Van den Berghe, H. (1994). Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias. British Journal of Haematology, 87, 523–528. 10.1111/j.1365-2141.1994.tb08307.x CASPubMedWeb of Science®Google Scholar D'Arena, G., Vitale, C., Rossi, G., Coscia, M., Omedè, P., D'Auria, F., Statuto, T., Valvano, L., Ciolli, S., Gilestro, M., Molica, S., Bellesi, S., Topini, G., Panichi, V., Autore, F., Innocenti, I., Musto, P., Deaglio, S., Laurenti, L., & Del Vecchio, L. (2018). CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia. Hematological Oncology, 36, 543–546. 10.1002/hon.2510 Web of Science®Google Scholar Darwiche, W., Gubler, B., Marolleau, J. P., & Ghamlouch, H. (2018). Chronic lymphocytic leukemia B-cell normal cellular counterpart: Clues from a functional perspective. Frontiers in Immunology, 9, 683. 10.3389/fimmu.2018.00683 PubMedWeb of Science®Google Scholar Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E. J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., Müller-Hermelink, H. K., Gascoyne, R. D., Delabie, J., Rimsza, L. M., Braziel, R. M., Grogan, T. M., Campo, E., Jaffe, E. S., Dave, B. J., … Staudt, L. M. Lymphoma/Leukemia Molecular Profiling Project. (2006). Molecular diagnosis of Burkitt's lymphoma. The New England Journal of Medicine, 354, 2431–2442. 10.1056/NEJMoa055759 CASPubMedWeb of Science®Google Scholar De Rossi, G., Mauro, F. R., Lo Coco, F., Caruso, R., Niscola, P., Pasqualetti, D., & Mandelli, F. (1993). CD5 negative lymphocytosis mimicking typical B-chronic lymphocytic leukaemia. Description of 26 cases. Nouvelle Revue Française d'Hématologie (1978), 35, 451–455. CASPubMedWeb of Science®Google Scholar Demir, C., Kara, E., Ekinci, Ö., & Ebinç, S. (2017). Clinical and laboratory features of CD5-negative chronic lymphocytic leukemia. Medical Science Monitor, 23, 2137–2142. 10.12659/MSM.901781 CASPubMedWeb of Science®Google Scholar Deneys, V., Michaux, L., Leveugle, P., Mazzon, A. M., Gillis, E., Ferrant, A., Scheiff, J. M., & De Bruyère, M. (2001). Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: Flow cytometric distinction by the use of CD20 and CD54 expression. Leukemia, 15, 1458–1465. 10.1038/sj.leu.2402200 CASPubMedWeb of Science®Google Scholar Döhner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Kröber, A., Bullinger, L., Döhner, K., Bentz, M., & Lichter, P. (2000). Genomic aberrations and survival in chronic lymphocytic leukemia. The New England Journal of Medicine, 343, 1910–1916. 10.1056/NEJM200012283432602 CASPubMedWeb of Science®Google Scholar Efstathiou, S., Tsioulos, D., Zacharos, I., Tsiakou, A., Mastorantonakis, S., Salgami, E., Katirtzoglou, N., Psarra, A., & Roussou, P. (2002). The prognostic role of CD5 negativity in B-cell chronic lymphocytic leukaemia: A case-control study. Haematologia (Budap), 32, 209–218. 10.1163/15685590260461020 CASPubMedGoogle Scholar Ellison, D. J., Nathwani, B. N., Cho, S. Y., & Martin, S. E. (1989). Interfollicular small lymphocytic lymphoma: The diagnostic significance of pseudofollicles. Human Pathology, 20, 1108–1118. 10.1016/0046-8177(89)90231-1 CASPubMedWeb of Science®Google Scholar Faguet, G. B., Marti, G. E., Agee, J. F., & Bertin, P. (1992). CD5 positive and negative B-CLL. Evidence supporting phenotypic heterogeneity in B-chronic lymphocytic leukemia (B-CLL). Annals of the New York Academy of Sciences, 651, 470–473. 10.1111/j.1749-6632.1992.tb24648.x CASPubMedWeb of Science®Google Scholar Flier, F. J., & de Vries Robbé, P. F. (1999). Nosology and causal necessity; the relation between defining a disease and discovering its necessary cause. Theoretical Medicine and Bioethics, 20, 577–588. 10.1023/A:1009994603779 CASPubMedWeb of Science®Google Scholar Gagliardi, F. (2022). Nosological diagnosis, theories of categorization, and argumentations by analogy. The Journal of Medicine and Philosophy, 47, 311–330. 10.1093/jmp/jhab048 PubMedWeb of Science®Google Scholar Gall, E. A., & Mallory, T. B. (1942). Malignant lymphoma: A clinico-pathologic survey of 618 cases. The American Journal of Pathology, 18, 381–429. CASPubMedWeb of Science®Google Scholar Galton, D. A. G. (1963). The natural history of chronic lymphocytic leukemia. M.D. thesis, Cambridge University, Cambridge. Google Scholar Garces, S., Khoury, J. D., Kanagal-Shamanna, R., Salem, A., Wang, S. A., Ok, C. Y., Hu, S., Patel, K. P., Routbort, M. J., Luthra, R., Tang, G., Schlette, E. J., Bueso-Ramos, C. E., Medeiros, L. J., & Loghavi, S. (2018). Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption. Human Pathology, 82, 215–231. 10.1016/j.humpath.2018.07.030 CASPubMedWeb of Science®Google Scholar Geisler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, Nielsen H, Plesner T, Thorling K, Andersen E, et al. (1991) Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood, 78(7), 1795–1802. 10.1182/blood.V78.7.1795.1795 CASPubMedWeb of Science®Google Scholar Gibson, S. E., Swerdlow, S. H., Ferry, J. A., Surti, U., Dal Cin, P., Harris, N. L., & Hasserjian, R. P. (2011). Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica, 96, 1144–1152. 10.3324/haematol.2011.042333 PubMedWeb of Science®Google Scholar Giné, E., Martinez, A., Villamor, N., López-Guillermo, A., Camos, M., Martinez, D., Esteve, J., Calvo, X., Muntañola, A., Abrisqueta, P., Rozman, M., Rozman, C., Bosch, F., Campo, E., & Montserrat, E. (2010). Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica, 95, 1526–1533. 10.3324/haematol.2010.022277 CASPubMedWeb of Science®Google Scholar Güell, N., Mozas, P., Jimenez-Rueda, A., Miljkovic, M., Juncà, J., & Sorigue, M. (2023). Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders. Critical Reviews in Clinical Laboratory Sciences, 60, 83–100. 10.1080/10408363.2022.2114418 PubMedWeb of Science®Google Scholar Hamblin, T. (2000). Historical aspects of chronic lymphocytic leukaemia. British Journal of Haematology, 111, 1023–1034. 10.1111/j.1365-2141.2000.02215.x CASPubMedWeb of Science®Google Scholar Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P. G., Knowles, D. M., Mason, D. Y., Muller-Hermelink, H. S., Pileri, S. A., Piri, M. A., Ralfkiare, E., & Warnke, R. A. (1994). A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84, 1361–1392. 10.1182/blood.V84.5.1361.1361 CASPubMedWeb of Science®Google Scholar Huang, J. C., Finn, W. G., Goolsby, C. L., Variakojis, D., & Peterson, L. C. (1999). CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia. American Journal of Clinical Pathology, 111, 123–130. 10.1093/ajcp/111.1.123 CASPubMedWeb of Science®Google Scholar Hwang, K., Park, C. J., Park, S. J., Jang, S., Chi, H. S., Cha, C. H., Huh, J. R., & Suh, C. W. (2009). A case of CD5 negative chronic lymphocytic leukemia. The Korean Journal of Hematology, 44, 255–260. 10.5045/kjh.2009.44.4.255 Google Scholar Ikematsu, W., Ikematsu, H., Okamura, S., Otsuka, T., Harada, M., & Niho, Y. (1994). Surface phenotype and Ig heavy-chain gene usage in chronic B-cell leukemias: Expression of myelomonocytic surface markers in CD5- chronic B-cell leukemia. Blood, 83, 2602–2610. 10.1182/blood.V83.9.2602.2602 CASPubMedWeb of Science®Google Scholar Inamdar, K. V., & Bueso-Ramos, C. E. (2007). Pathology of chronic lymphocytic leukemia: An update. Annals of Diagnostic Pathology, 11, 363–389. 10.1016/j.anndiagpath.2007.08.002 PubMedWeb of Science®Google Scholar Ivancević, T. D., Kurtović, N. K., Knezević, V., Bogdanović, A., Mihaljević, B., Bozić, B., & Gotić, M. (2014). The role of immunophenotyping in differential diagnosis of chronic lymphocytic leukemia. Srpski arhiv za celokupno lekarstvo, 142, 197–203. 10.2298/SARH1404197D PubMedWeb of Science®Google Scholar Jaffe, E. S., Harris, N. L., Stein, H., & Isaacson, P. G. (2008). Classification of lymphoid neoplasms: The microscope as a tool for disease discovery. Blood, 112, 4384–4399. 10.1182/blood-2008-07-077982 CASPubMedWeb of Science®Google Scholar Keung, Y. K., Buss, D., Pettenati, M., & Powell, B. L. (2002). CD5-negative chronic lymphocytic leukemia or monoclonal B-lymphocytosis of undetermined significance? American Journal of Hematology, 70, 334. 10.1002/ajh.10160 CASPubMedWeb of Science®Google Scholar Kilo, M. N., & Dorfman, D. M. (1996). The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. American Journal of Clinical Pathology, 105, 451–457. 10.1093/ajcp/105.4.451 CASPubMedWeb of Science®Google Scholar Kim, O. K., Cheon, J. S., Kim, H. J., Lee, G. H., An, Y. J., Ha, J. H., Oh, K. S., Lee, S. R., Kim, H., Jum, I. S., Kim, M. Y., & Lee, J. N. (1999). A case of CD5 negative B-cell chronic lymphocytic leukemia. Korean Journal of Medicine, 56, 235–239. Google Scholar Kundrat, H. (1893). Ueber Lympho-Sarkomatosis. Wiener klinische Wochenschrift, 6, 211–213. Google Scholar Kurec, A. S., Threatte, G. A., Gottlieb, A. J., Smith, J. R., Anderson, J., & Davey, F. R. (1992). Immunophenotypic subclassification of chronic lymphocytic leukaemia (CLL). British Journal of Haematology, 81, 45–51. 10.1111/j.1365-2141.1992.tb08169.x CASPubMedWeb of Science®Google Scholar Köhnke, T., Wittmann, V. K., Bücklein, V. L., Lichtenegger, F., Pasalic, Z., Hiddemann, W., Spiekermann, K., & Subklewe, M. (2017). Diagnosis of CLL revisited: Increased specificity by a modified five-marker scoring system including CD200. British Journal of Haematology, 179, 480–487. 10.1111/bjh.14901 CASPubMedWeb of Science®Google Scholar Laurence, S., & Margolis, E. (1999). Concepts and cognitive science. In S. Laurence & E. Margolis (Eds.), Concepts: Core readings (pp. 3–81). MIT Press. Web of Science®Google Scholar Lennert, K., & Mohri, N. (1978). Histopathology and diagnosis of non-Hodgkin's lymphomas. In K. Lennert & N. Mohri (Eds.), Malignant lymphomas other than Hodgkin's disease: Histology· cytology· ultrastructure·immunology (pp. 111–470). Springer Science & Business Media. 10.1007/978-3-642-81092-3_4 Google Scholar Lennert, K., Tamm, I., & Wacker, H. H. (1991). Histopathology and immunocytochemistry of lymph node biopsies in chronic lymphocytic leukemia and immunocytoma. Leukemia Lymphoma, 5, 157–160. 10.3109/10428199109103399 PubMedWeb of Science®Google Scholar Li, Y., Tong, X., Huang, L., Li, L., Wang, C., He, C., Liu, S., Wang, Z., Xiao, M., Mao, X., & Zhang, D. (2021). A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia. Cancer Medicine, 10, 4387–4396. 10.1002/cam4.3983 CASPubMedWeb of Science®Google Scholar Loscalzo, J., Kohane, I., & Barabasi, A. L. (2007). Human disease classification in the postgenomic era: A complex systems approach to human pathobiology. Molecular Systems Biology, 3, 124. 10.1038/msb4100163 PubMedWeb of Science®Google Scholar Maloum, K., Davi, F., Magnac, C., Pritsch, O., McIntyre, E., Valensi, F., Binet, J. L., Merle-Béral, H., & Dighiero, G. (1995). Analysis of VH gene expression in CD5+ and CD5- B-cell chronic lymphocytic leukemia. Blood, 86, 3883–3890. 10.1182/blood.V86.10.3883.bloodjournal86103883 CASPubMedWeb of Science®Google Scholar Maloum, K., Pritsch, O., Magnac, C., Davi, F., Binet, J. L., Merle-Beral, H., & Dighiero, G. (1997). VH gene expression in CD5 positive and CD5 negative B cell chronic lymphoid malignancies. Leukemia Lymphoma, 24, 437–448. 10.3109/10428199709055582 CASPubMedWeb of Science®Google Scholar Marti, G. E., & Zenger, V. (2010). The natural history of CLL. In G. B. Faguet (Ed.), Chronic lymphocytic leukemia: Molecular genetics biology diagnosis and management (pp. 3–54). Humana Press. Google Scholar Matos, D. M. (2019). CD8 antigen expression in chronic lymphocytic leukemia: Does it have any relevant meaning? Cytometry Part B, Clinical Cytometry, 96, 96–98. 10.1002/cyto.b.21759 PubMedWeb of Science®Google Scholar Matos, D. M. (2023). CD2+ hairy cell leukemia. Acta Haematologica Polonica, 54, 200–202. 10.5603/AHP.a2023.0026 Google Scholar Matos, D. M., Kaufman, J., Scrideli, C. A., & Falcão, R. P. (2018). Sézary syndrome with T/NK phenotype: A variant phenotype or a distinct clinical entity? Cytometry Part B, Clinical Cytometry, 94, 561–563. 10.1002/cyto.b.21381 PubMedWeb of Science®Google Scholar Matos, D. M., Perini, G., Kruzich, C., Rego, E. M., & Falcão, R. P. (2009). Smudge cells in peripheral blood smears did not differentiate chronic lymphocytic leukemia from other B-cell chronic lymphoprolipherative diseases. Revista Brasileira de Hematologia e Hemoterapia, 31, 333–336. 10.1590/S1516-84842009005000069 Google Scholar Matutes, E., Oscier, D., Garcia-Marco, J., Ellis, J., Copplestone, A., Gillingham, R., Hamblin, T., Lens, D., Swansbury, G. J., & Catovsky, D. (1996). Trisomy 12 defines a group of CLL with atypical morphology: Correlation between cytogenetic, clinical and laboratory features in 544 patients. British Journal of Haematology, 92, 382–388. 10.1046/j.1365-2141.1996.d01-1478.x CASPubMedWeb of Science®Google Scholar Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia Marco, J., Houlihan, A., Que, T. H., & Catovsky, D. (1994). The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia, 8, 1640–1645. CASPubMedWeb of Science®Google Scholar Medin, D. L. (1989). Concepts and conceptual structure. American Psychologist, 44, 1469–1481. 10.1037/0003-066X.44.12.1469 CASPubMedWeb of Science®Google Scholar Moreau, E. J., Matutes, E., A'Hern, R. P., Morilla, A. M., Morilla, R. M., Owusu-Ankomah, K. A., Seon, B. K., & Catovsky, D. (1997). Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). American Journal of Clinical Pathology, 108, 378–382. 10.1093/ajcp/108.4.378 CASPubMedWeb of Science®Google Scholar Morice, W. G., Kurtin, P. J., Hodnefield, J. M., Shanafelt, T. D., Hoyer, J. D., Remstein, E. D., & Hanson, C. A. (2008). Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: Comparative analysis of flow cytometry and tissue biopsy in 252 patients. Mayo Clinic Proceedings, 83, 776–785. 10.4065/83.7.776 PubMedWeb of Science®Google Scholar Murphy, G. L. (2002). The big book of concepts (pp. 17–22). MIT Press. Google Scholar Myles, N., Giri, P., Chim, I., & Kodituwakku, A. (2021). The utility of CD200 expression and modified Matutes score in the diagnostic differentiation of mantle cell lymphoma and chronic lymphocytic leukemia using flow cytometry. Leukemia Lymphoma, 62, 504–506. 10.1080/10428194.2019.1663420 PubMedWeb of Science®Google Scholar Nakamura, N., Suzuki, S., Segami, H., Nozawa, Y., Tominaga, K., Wachi, E., Hojo, H., Abe, M., Sakuma, H., & Wakasa, H. (1994). Clinicopathological and immunophenotypic studies on 12 cases with B cell chronic lymphocytic leukemia. Pathology International, 44, 779–784. 10.1111/j.1440-1827.1994.tb02926.x CASPubMedWeb of Science®Google Scholar Navarro, A., Clot, G., Martínez-Trillos, A., Pinyol, M., Jares, P., González-Farré, B., Martínez, D., Trim, N., Fernández, V., Villamor, N., Colomer, D., Costa, D., Salaverria, I., Martín-Garcia, D., Erber, W., López, C., Jayne, S., Siebert, R., Dyer, M. J. S., … Beà, S. (2017). Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier. Haematologica, 102, e360–e363. 10.3324/haematol.2016.160374 CASPubMedWeb of Science®Google Scholar Nguyen, D. T., Diamond, L. W., Schwonzen, M., Bohlen, H., & Diehl, V. (1995). Chronic lymphocytic leukemia with an interfollicular architecture: Avoiding diagnostic confusion with monocytoid B-cell lymphoma. Leukemia Lymphoma, 18, 179–184. 10.3109/10428199509064940 CASPubMedWeb of Science®Google Scholar Oka, K., Mori, N., & Yatabe, Y. (1993). Immunohistochemical characteristics of monocytoid B cell lymphoma, mantle zone lymphoma, small lymphocytic lymphoma (or B chronic lymphocytic leukemia), and hairy cell leukemia. Acta Haematologica, 90, 84–89. 10.1159/000204381 CASPubMedWeb of Science®Google Scholar Que, T. H., Marco, J. G., Ellis, J., Matutes, E., Babapulle, V. B., Boyle, S., & Catovsky, D. (1993). Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Analysis by stage, immunophenotype, and morphology. Blood, 82, 571–575. 10.1182/blood.V82.2.571.571 CASPubMedWeb of Science®Google Scholar Rai, K. R. (1993). Progress in chronic lymphocytic leukaemia: A historical perspective. Baillière's Clinical Haematology, 6, 757–765. 10.1016/S0950-3536(05)80174-X CASPubMedGoogle Scholar Rawstron, A. C., Kreuzer, K. A., Soosapilla, A., Spacek, M., Stehlikova, O., Gambell, P., McIver-Brown, N., Villamor, N., Psarra, K., Arroz, M., Milani, R., de la Serna, J., Cedena, M. T., Jaksic, O., Nomdedeu, J., Moreno, C., Rigolin, G. M., Cuneo, A., Johansen, P., … Montserrat, E. (2018). Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. Cytometry Part B, Clinical Cytometry, 94, 121–128. 10.1002/cyto.b.21595 CASPubMedWeb of Science®Google Scholar Rawstron, A., de Tute, R. M., Shingles, J., Gorman, L., Turner, K., Evans, P. A. S., Barrans, S. L., O'Connor, S. J., M., Burton, C., Owen, R. G., & Hillmen, P. (2016). Improving the differential diagnosis of CD5+ B-lymphoproliferative disorders. EHA Meet, 101, 225.. Google Scholar Romano C, Sellitto A, Chiurazzi F, Simeone L, De Fanis U, Raia M, Del Vecchio L, Lucivero G. (2015). Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia. Int J Hematol, 101(1), 67–74. 10.1007/s12185-014-1703-y CASPubMedWeb of Science®Google Scholar Rosenwald, A., Alizadeh, A. A., Widhopf, G., Simon, R., Davis, R. E., Yu, X., Yang, L., Pickeral, O. K., Rassenti, L. Z., Powell, J., Botstein, D., Byrd, J. C., Grever, M. R., Cheson, B. D., Chiorazzi, N., Wilson, W. H., Kipps, T. J., Brown, P. O., & Staudt, L. M. (2001). Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. Journal of Experimental Medicine, 194, 1639–1647. 10.1084/jem.194.11.1639 CASPubMedWeb of Science®Google Scholar Sadegh-Zadeh, K. (2000). Fuzzy health, illness, and disease. The Journal of Medicine and Philosophy, 25, 605–638. 10.1076/0360-5310(200010)25:5;1-W;FT605 CASPubMedWeb of Science®Google Scholar Salomon-Nguyen, F., Valensi, F., Merle-Beral, H., & Flandrin, G. (1995). A scoring system for the classification of CD5-B CLL versus CD5+ B CLL and B PLL. Leukemia Lymphoma, 16, 445–450. 10.3109/10428199509054432 CASPubMedWeb of Science®Google Scholar Scadding, J. G. (1959). Principles of definition in medicine with special reference to chronic bronchitis and emphysema. Lancet, 1, 323–325. 10.1016/S0140-6736(59)90308-3 CASPubMedWeb of Science®Google Scholar Sedler, M. J. (1994). Foundations of the new nosology. The Journal of Medicine and Philosophy, 19, 219–238. 10.1093/jmp/19.3.219 CASPubMedWeb of Science®Google Scholar Severinsen, M. (2001). Principles behind definitions of diseases–a criticism of the principle of disease mechanism and the development of a pragmatic alternative. Theoretical Medicine and Bioethics, 22, 319–336. 10.1023/A:1011830602137 CASPubMedWeb of Science®Google Scholar Shapiro, J. L., Miller, M. L., Pohlman, B., Mascha, E., & Fishleder, A. J. (1999). CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients. American Journal of Clinical Pathology, 111, 477–487. 10.1093/ajcp/111.4.477 CASPubMedWeb of Science®Google Scholar Sheikh, S. S., Kallakury, B. V., Al-Kuraya, K. A., Meck, J., Hartmann, D. P., & Bagg, A. (2002). CD5-negative, CD10-negative small B-cell leukemia: Variant of chronic lymphocytic leukemia or a distinct entity? American Journal of Hematology, 71, 306–310. 10.1002/ajh.10222 PubMedWeb of Science®Google Scholar Simon, J. R. (2008). Constructive realism and medicine: An approach to medical ontology. Perspective in Biology and Medicine, 51, 353–366. 10.1353/pbm.0.0032 PubMedWeb of Science®Google Scholar Soma, L. A., Craig, F. E., & Swerdlow, S. H. (2006). The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. Human Pathology, 37, 152–159. 10.1016/j.humpath.2005.09.029 CASPubMedWeb of Science®Google Scholar Song, J. H., Kim, H. J., Lee, C. H., Kim, S. J., Hwang, S. Y., & Kim, T. S. (2006). Identification of gene expression signatures for molecular classification in human leukemia cells. International Journal of Oncology, 29, 57–64. CASPubMedWeb of Science®Google Scholar Sorigue, M., Junca, J., Ferra, C., Marce, S., Ruiz-Xivillé, N., Pinyol, L., Cabezon, M., Espasa, A., Dominguez, D., Lopez-Viaplana, L., Ruiz, R., Buch, J., Plensa, E., Mostacedo, S. Z., Aranda, J., Vergara, S., Raya, M., Granada, I., Tapia, G., … Zamora, L. (2020). FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study. Cytometry Part B, Clinical Cytometry, 98, 421–428. 10.1002/cyto.b.21890 CASPubMedWeb of Science®Google Scholar Sorigue, M., Raya, M., Vergara, S., Sarrate, E., Orna, E., & Juncà, J. (2019). Refining the limits of borderline lymphoproliferative disorders. Cytometry Part B, Clinical Cytometry, 96, 351–358. 10.1002/cyto.b.21760 CASPubMedWeb of Science®Google Scholar Specchia, G., Albano, F., Anelli, L., Storlazzi, C. T., Monaco, M., Capalbo, S., Rocchi, M., & Liso, V. (2002). Concomitant tetrasomy 3q and trisomy 18 in CD5(−), CD13(+) chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics, 133, 160–163. 10.1016/S0165-4608(01)00583-0 CASPubMedGoogle Scholar Sulmasy, D. P. (2005). Diseases and natural kinds. Theoretical Medicine and Bioethics, 26, 487–513. 10.1007/s11017-005-2206-x PubMedWeb of Science®Google Scholar Swerdlow, S. H., Campo, E., Harris, N. L., Jaffe, E. S., Pileri, S. A., & Stein, H. (2017). WHO classification of tumours of haematopoietic and lymphoid tissues ( 4th ed., p. 286). International Agency for Research on Cancer. Google Scholar Swerdlow, S. H., Zukerberg, L. R., Yang, W. I., Harris, N. L., & Williams, M. E. (1996). The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements. American Journal of Surgical Pathology, 20, 627–640. 10.1097/00000478-199605000-00009 CASPubMedWeb of Science®Google Scholar Teixeira Mendes, L. S., Peters, N., Attygalle, A. D., & Wotherspoon, A. (2017). Cyclin D1 overexpression in proliferation centres of small lymphocytic lymphoma/chronic lymphocytic leukaemia. Journal of Clinical Pathology, 70, 899–902. 10.1136/jclinpath-2017-204364 PubMedWeb of Science®Google Scholar Turk, W. (1903). Ein System der Lymphomatosen. Wiener klinische Wochenschrift, 16, 1073–1085. Google Scholar Urbaniak, M., Iskierka-Jażdżewska, E., Majchrzak, A., & Robak, T. (2022). Atypical immunophenotype of chronic lymphocytic leukemia. Acta Haematologica Polonica, 53, 48–52. 10.5603/AHP.a2021.0096 Google Scholar Vineis, P. (1993). Definition and classification of cancer: Monothetic or polythetic? Theoretical Medicine, 14, 249–256. 10.1007/BF00995166 CASPubMedGoogle Scholar Vineis, P. (2008). Methodological insights: Fuzzy sets in medicine. Journal of Epidemiology and Community Health, 62, 273–278. 10.1136/jech.2007.063644 CASPubMedWeb of Science®Google Scholar Virchow, R. (1845). Weisses Blut. In Neue Notizen aus dem Gebiete der Natur- und Heilkunde. Froriep's neue Notizen, 36, 151–156. Google Scholar Yamada, T., Ninomiya, H., Horiuchi, T., Takada, K., Hato, T., Yamauchi, K., Yasukawa, M., & Fujita, S. (1995). CD5-negative B-cell chronic lymphocytic leukemia (B-CLL) associated with massive splenomegaly and without lymphadenopathy. Rinshō Ketsueki, 36, 1230–1232. CASPubMedGoogle Scholar Yan, Y., Lv, R., Xiong, W., Li, Z., Wang, Y., Yu, Y., Yu, Z., Wang, T., Sui, W., Liu, W., Zou, D., Yi, S., & Qiu, L. (2020). Subtype distribution, clinical features, and survival in B-cell chronic lymphoproliferative disorders in China: A review of 1592 cases. Clinical Lymphoma, Myeloma & Leukemia, 20, e270–e283. 10.1016/j.clml.2019.11.002 PubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation
Referência(s)